Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell Carcinoma
The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting po...
Saved in:
Main Authors: | Meng Lian, Jiaming Chen, Xixi Shen, Lizhen Hou, Jugao Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2020/6452182 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma
by: Fanyong Kong, et al.
Published: (2023-01-01) -
Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma
by: Hiroki Sato, et al.
Published: (2018-01-01) -
PPARG Could Work as a Valid Therapeutic Strategy for the Treatment of Lung Squamous Cell Carcinoma
by: Shunbin Shi, et al.
Published: (2020-01-01) -
18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma
by: Shinsuke Suzuki, et al.
Published: (2022-04-01) -
The association between level IV/V metastasis and the recurrence, distant metastasis, and survival outcomes in hypopharyngeal squamous cell carcinoma
by: Ruichen Li, et al.
Published: (2025-01-01)